BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 7747571)

  • 1. A three-pore model describes transport properties of bovine retinal endothelial cells in normal and elevated glucose.
    Lopez-Quintero SV; Ji XY; Antonetti DA; Tarbell JM
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1171-80. PubMed ID: 21357410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of zebrafish retinal cells using fluorescent coumarin derivatives.
    Watanabe K; Nishimura Y; Oka T; Nomoto T; Kon T; Shintou T; Hirano M; Shimada Y; Umemoto N; Kuroyanagi J; Wang Z; Zhang Z; Nishimura N; Miyazaki T; Imamura T; Tanaka T
    BMC Neurosci; 2010 Sep; 11():116. PubMed ID: 20843315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
    Zhang X; Bao S; Lai D; Rapkins RW; Gillies MC
    Diabetes; 2008 Apr; 57(4):1026-33. PubMed ID: 18174522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.
    Sander B; Larsen M; Engler C; Strøm C; Moldow B; Larsen N; Lund-Andersen H
    Br J Ophthalmol; 2002 Mar; 86(3):316-20. PubMed ID: 11864891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of passive drug entry into the central nervous system.
    Habgood MD; Begley DJ; Abbott NJ
    Cell Mol Neurobiol; 2000 Apr; 20(2):231-53. PubMed ID: 10696512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-retina barrier permeability is independent of trace substance lipid solubility in retinitis pigmentosa and in the healthy eye.
    Larsen M; Engler CB; Haim M; Lund-Andersen H
    Int Ophthalmol; 1997-1998; 21(4):229-34. PubMed ID: 9700011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein transport across the human blood-retina barrier in the direction vitreous to blood. Quantitative assessment in vivo.
    Engler CB; Sander B; Larsen M; Dalgaard P; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):655-62. PubMed ID: 7747570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
    Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
    Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
    Moldow B; Sander B; Larsen M; Lund-Andersen H
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous flyorophotometry.
    Takahashi J; Mori F; Hikichi T; Yoshida A
    Curr Eye Res; 2001 Sep; 23(3):166-70. PubMed ID: 11803477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.